|
Market Closed -
NYSE
23:00:03 08/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 44.98 USD | -5.90% |
|
-6.45% | -52.83% |
| 01:35am | S&P 500 falls as AI worries hit software makers | RE |
| 09-09 | Health Care Down as Novartis, Boston Scientific Weigh - Health Care Roundup | DJ |
| Market Cap | 65.19B 56.05B 52.73B 48.12B 89.8B 6,180B 90.26B 625B 242B 3,159B 245B 239B 10,052B | P/E 2026 * |
16.8x | P/E 2027 * | 17.7x |
|---|---|---|---|---|---|
| Enterprise Value | 73.9B 63.54B 59.78B 54.55B 102B 7,006B 102B 708B 274B 3,581B 278B 271B 11,396B | EV / Sales 2026 * |
3.46x | EV / Sales 2027 * | 3.16x |
| Free-Float |
82.47% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| BSX | Delayed | |
CBOE
| BSX | Real-time | |
|
Mexican S.E.
| BSX * | End-of-day quote | |
|
Wiener Boerse
| BSXC | End-of-day quote | |
|
Tradegate
| BSX | Real-time | |
|
CBOE
| Real-time | ||
|
Börse Stuttgart
| BSX | Delayed | |
|
Boerse Muenchen
| BSX | Real-time | |
|
Borsa Italiana
| 1BSX | End-of-day quote | |
|
London S.E.
| 0HOY | Delayed | |
|
Xetra
| BSX | Delayed | |
|
Deutsche Boerse AG
| BSX | Delayed | |
|
Swiss Exchange
| BSX | Delayed | |
|
Swiss Exchange
| BSX | Delayed | |
|
CBOE
| 0HOY | Real-time |
Last Transcript : Boston Scientific Corporation
| 1 day | -5.90% | ||
| 1 week | -6.45% | ||
| Current month | -6.87% | ||
| 1 month | -8.78% | ||
| 3 months | -7.64% | ||
| 6 months | -36.96% | ||
| Current year | -52.83% |
| 1 week | 44.85 |  | 49.27 |
| 1 month | 44.85 | | 52.99 |
| Current year | 42.2 | | 100.9 |
| 1 year | 42.2 | | 108.07 |
| 3 years | 42.2 | | 109.5 |
| 5 years | 34.98 | | 109.5 |
| 10 years | 19.67 | | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 61 | 01/11/2011 |
Jonathan Monson
DFI | Director of Finance/CFO | 52 | 30/06/2025 |
Kenneth Stein
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CHM | Chairman | 61 | 03/05/2016 |
Edward Ludwig
BRD | Director/Board Member | 74 | 01/03/2014 |
Ellen Zane
BRD | Director/Board Member | 74 | 15/04/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/25/26 A | Buy | Director | 2,040 | 0.0001% | ||
| 8/11/26 A | Other | Controller/Auditor | 2,930 | 0.0002% | ||
| 8/10/26 A | Other | Chief Financial Officer | 9,908 | 0.0007% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.90% | -6.45% | -58.41% | -16.50% | 65.19B | |
| -1.75% | +0.42% | +23.66% | +16.35% | 223B | |
| -1.17% | -0.82% | +3.32% | -17.37% | 144B | |
| -4.51% | -5.17% | -25.50% | +17.42% | 124B | |
| -3.54% | -4.43% | +8.12% | +17.08% | 49.99B | |
| -0.58% | -1.67% | -17.87% | -14.27% | 50.49B | |
| -2.66% | -2.05% | +14.61% | +28.83% | 41.4B | |
| -1.58% | -0.72% | +30.24% | +52.87% | 39.59B | |
| -3.28% | +1.90% | +114.97% | +33.28% | 31.87B | |
| -3.20% | -4.46% | -20.90% | +49.41% | 31.62B | |
| Average | -2.10% | -2.19% | +7.22% | +16.71% | 80.11B | |
| Weighted average by Cap. | -1.50% | -1.91% | +3.87% | +10.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.37B 18.37B 17.28B 15.77B 29.44B 2,026B 29.59B 205B 79.23B 1,035B 80.24B 78.49B 3,295B | 22.34B 19.21B 18.07B 16.49B 30.77B 2,118B 30.93B 214B 82.83B 1,082B 83.88B 82.05B 3,444B |
| Net income | 3.84B 3.3B 3.11B 2.83B 5.29B 364B 5.32B 36.79B 14.24B 186B 14.42B 14.1B 592B | 3.69B 3.17B 2.98B 2.72B 5.08B 349B 5.1B 35.33B 13.67B 179B 13.84B 13.54B 568B |
| Net Debt | 8.72B 7.49B 7.05B 6.43B 12.01B 826B 12.07B 83.55B 32.32B 422B 32.73B 32.02B 1,344B | 5.45B 4.69B 4.41B 4.02B 7.51B 517B 7.55B 52.25B 20.22B 264B 20.47B 20.02B 841B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/09/26 | $44.98 | -5.90% | 29,028,776 |
| 04/09/26 | $47.80 | +1.81% | 15,504,234 |
| 03/09/26 | $46.95 | -2.94% | 19,732,249 |
| 02/09/26 | $48.37 | +0.60% | 17,017,972 |
| 01/09/26 | $48.08 | -0.46% | 12,004,264 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions
